Stuttgart
03.07.25 | 09:13
1,820 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,830 | 1,850 | 10:17 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.06. | CareRx Corp: CareRx shareholders approve AGM resolutions | 1 | Stockwatch | ||
| 06.06. | CareRx Corporation: CareRx Reports Voting Results from Annual General Meeting of Shareholders | 709 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate... ► Artikel lesen | |
| CARERX Aktie jetzt für 0€ handeln | |||||
| 07.05. | CareRx Corporation: CareRx Reports Results for the First Quarter of 2025 | 140 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 7, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate... ► Artikel lesen | |
| 30.04. | CareRx Corp: CareRx to release Q1 2025 financial results May 7 | 1 | Stockwatch | ||
| 30.04. | Stocks in Play: CareRx Corporation | 1 | Baystreet.ca | ||
| 30.04. | CareRx Corporation to Host First Quarter 2025 Financial Results Conference Call on Wednesday, May 7, 2025 at 10:30 a.m. ET | 123 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation, to discuss... ► Artikel lesen | |
| 06.03. | CareRx wins price target raise at Desjardins | 4 | Cantech Letter | ||
| 06.03. | CareRx Corp: CareRx loses $4.5-million in 2024 | 2 | Stockwatch | ||
| 05.03. | CareRx GAAP EPS of -C$0.04, revenue of C$92.2M | 1 | Seeking Alpha | ||
| 05.03. | Stocks in Play: CareRx Corporation | 2 | Baystreet.ca | ||
| 05.03. | CareRx Corporation: CareRx Reports Results for the Fourth Quarter of 2024 | 318 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 5, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate... ► Artikel lesen | |
| 26.02. | CareRx Corp: CareRx to release 2024 results March 5 | 1 | Stockwatch | ||
| 25.02. | CareRx Corporation to Host Fourth Quarter 2024 Financial Results Conference Call on Wednesday, March 5, 2025 at 8:30 a.m. ET | 272 | Newsfile | Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation,... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,380 | +0,24 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Fresenius auf "Buy" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| DRAEGERWERK | 66,20 | +0,15 % | Draegerwerk AG & Co. KGaA: Konstruktive Präsentation auf der mwb research-Konferenz; mwb research empfiehlt HALTEN | Auf der gestrigen mwb research Health Care Conference bestätigte Drägers Head of Investor Relations, Thomas Fischler, den Ausblick für das Geschäftsjahr 2025 (Umsatzwachstum 1-5%, EBIT-Marge 3,5-6,5%)... ► Artikel lesen | |
| THERMO FISHER | 361,40 | -0,29 % | GenNext Technologies und Thermo Fisher Scientific arbeiten zusammen | ||
| ORGANON | 8,552 | -0,60 % | Karolinska Development AB (publ): Karolinska Development receives update from Organon concerning OG-6219 | ||
| PERIMETER MEDICAL IMAGING AI | 0,156 | 0,00 % | Perimeter Medical Imaging AI Inc: Perimeter Medical makes OCT sale to Dallas hospital | ||
| OPTIMA HEALTH | 2,340 | 0,00 % | Optima Health to acquire Cognate Health Limited | The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 58,18 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,750 | -1,18 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 22,010 | 0,00 % | BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth | ||
| ALIGNMENT HEALTHCARE | 13,610 | -4,22 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 54,95 | -2,92 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,340 | -0,17 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen auf "Buy" mit einem Kursziel von 60 Euro belassen. Julien Dormois fasste in einer am Donnerstag... ► Artikel lesen | |
| MIMEDX | 6,230 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2025 Operating and Financial Results | Net Sales of $88 million Grew 4% Year-Over-Year for the First Quarter First Quarter GAAP Net Income and Earnings Per Share were $7 Million and $0.05, Respectively First Quarter Adjusted EBITDA... ► Artikel lesen | |
| NUTEX HEALTH | 122,29 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| GENEDX | 89,79 | 0,00 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts |
CARERX CORPORATION gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,820 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CARERX CORPORATION finden Sie auf Wallstreet Online.